MS
Morgan Stanley
MS's fundamentals are strong: revenue grew 16% and earnings per share grew 29%. At 15x earnings, it's trading in line with its usual 14x. Analysts expect earnings growth.
OXBR
Oxbridge Re Holdings Limited
There isn't enough reported data to score OXBR yet.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
OXBR Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| N/A | |
| N/A |
OXBR's profitability is currently stable, but its revenue is under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like OXBR.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
OXBR PE Valuation
OXBR has no meaningful PE right now: it lost money over the past year.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
OXBR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong decline | |
| -- | |
| Limited | |
| High |
Analysts expect OXBR's losses to grow, with revenue declining.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over OXBR on earnings quality, reporting a profit while its opponent remains loss making.
OXBR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.02 | +$0.34 |
| Q2 2026 | $0.01 | +$0.44 |
| Q1 2026 | -$0.26 | +$0.06 |
| Q2 2022 | $1.35 | +1250% |
| Q1 2022 | $1.42 | +2740% |
OXBR is still losing money, but far less than before: $0.02 per share over the past year, against $0.43 at its worst in mid-2025.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over OXBR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over OXBR on profitability, with a higher operating margin.
OXBR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $261K | -60% |
| Q2 2026 | $940K | +42% |
| Q1 2026 | $623K | -10% |
| Q4 2025 | $576K | +36% |
| Q3 2025 | $645K | +215% |
| Q2 2025 | $664K | +1409% |
| Q2 2024 | $44K | -94% |
| Q2 2023 | $691K | +37% |
OXBR's revenue fell from its 2021 peak and has held roughly level since: $261,000 last quarter, down 60% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -149% | -122 points |
| Q2 2026 | 31% | +333 points |
| Q1 2026 | 6.1% | +24 points |
| Q4 2025 | 39% | +57 points |
| Q3 2025 | -27% | +116 points |
| Q2 2025 | -302% | +1026 points |
| Q1 2025 | -18% | N/A |
| Q4 2024 | -18% | N/A |
OXBR's operating margin was −149% last quarter, down 122 points from the same quarter a year ago, near the bottom of its range since 2019.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS has the edge over OXBR on cash flow, with more consistent year-over-year improvement.
OXBR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$317K | -369% |
| Q2 2026 | -$267K | +$1.9M |
| Q1 2026 | $210K | -23% |
| Q2 2023 | -$1.5M | -$1.1M |
| Q1 2023 | -$145K | -$76K |
| Q2 2022 | -$406K | -$265K |
| Q1 2022 | -$69K | -$2K |
| Q4 2021 | -$146K | -1317% |
OXBR's free cash flow was $59,000 over the past year, against −$3M the year before. Free cash flow isn't a meaningful measure for financial services companies like OXBR.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over OXBR on shareholder dilution, with a more favorable share count trend.
OXBR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +23.6K shares |
| 1 year | +6% | +461K shares |
| 3 years | +41% | +2.4M shares |
| 5 years | +42% | +2.4M shares |
OXBR has 8M diluted shares, up 6% from a year ago.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
OXBR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2022 | -0.6x | Net Cash |
| Q4 2021 | -0.4x | Net Cash |
| Q3 2021 | -0.8x | Net Cash |
| Q2 2021 | -10.9x | Net Cash |
| Q1 2021 | -10.4x | Net Cash |
OXBR has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like OXBR.
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
OXBR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.3 | Neutral |
| Stochastic | 17.7 | Oversold |
OXBR's weekly RSI is 40 (neutral) and its Stochastic is 18 (oversold).
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS has the edge over OXBR on valuation relative to its sector.
OXBR PE vs Financial Services Sector
| Metric | OXBR | Sector median | Relative |
|---|---|---|---|
| PE | 68x | 13x | 424% above |
| PE % | 82 | 63 | 19 pts above |
OXBR has no meaningful PE right now: it lost money over the past year.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS has the edge over OXBR on trend strength, trading above more of its moving averages.
OXBR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.00 | 13% below |
| 20 week MA | $1.27 | 31% below |
| 50 week MA | $1.14 | 24% below |
| 100 week MA | $1.78 | 51% below |
| 200 week MA | $1.77 | 51% below |
OXBR is in a downtrend: it's below all five of its weekly moving averages, and 51% below its 200-week average.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has the edge over OXBR on returns for 2026, with the stronger performance.
OXBR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $0.74 | $1.68 | +127% |
| 2021 | $1.68 | $6.96 | +314% |
| 2022 | $6.96 | $1.25 | -82% |
| 2023 | $1.25 | $1.10 | -12% |
| 2024 | $1.10 | $4.81 | +337% |
| 2025 | $4.81 | $1.23 | -74% |
| 2026 YTD | $1.23 | $0.87 | -29% |
OXBR's yearly returns have swung widely, from +337% in 2024 to −82% in 2022. It's down 29% so far in 2026.